Compare JD & IQV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | JD | IQV |
|---|---|---|
| Founded | 2006 | 1982 |
| Country | China | United States |
| Employees | N/A | N/A |
| Industry | Other Specialty Stores | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.3B | 36.4B |
| IPO Year | 2014 | 2013 |
| Metric | JD | IQV |
|---|---|---|
| Price | $29.50 | $225.11 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 17 |
| Target Price | $42.00 | ★ $237.59 |
| AVG Volume (30 Days) | ★ 11.7M | 1.4M |
| Earning Date | 11-13-2025 | 10-28-2025 |
| Dividend Yield | ★ 3.38% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | 2.99 | ★ 7.30 |
| Revenue | ★ $183,136,729,092.00 | $15,904,000,000.00 |
| Revenue This Year | $15.80 | $6.14 |
| Revenue Next Year | $5.55 | $5.35 |
| P/E Ratio | ★ $9.89 | $30.94 |
| Revenue Growth | ★ 16.63 | 3.85 |
| 52 Week Low | $28.21 | $134.65 |
| 52 Week High | $46.45 | $234.30 |
| Indicator | JD | IQV |
|---|---|---|
| Relative Strength Index (RSI) | 40.49 | 55.28 |
| Support Level | $29.11 | $217.86 |
| Resistance Level | $29.90 | $230.80 |
| Average True Range (ATR) | 0.43 | 5.52 |
| MACD | 0.15 | -1.08 |
| Stochastic Oscillator | 68.38 | 53.14 |
JD.com is the third-largest Chinese e-commerce platform by gross merchandise volume in 2024. it offers a wide selection of authentic products with speedy and reliable delivery. The company has built its own nationwide fulfilment infrastructure and last-mile delivery network, staffed by its own employees, which supports both its online direct sales, its online marketplace and omnichannel businesses.
Iqvia is the result of the 2016 merger of Quintiles, a leading global contract research organization, and IMS Health, a leading healthcare data and analytics provider. The research and development segment focuses primarily on providing outsourced late-stage clinical trials for pharmaceutical, device, and diagnostic firms. The technology and analytics segment provides aggregated information and technology services to clients in the healthcare industry, including pharmaceutical companies, providers, payers, and policymakers, as well as data and analytics capabilities for clinical trials, including virtual trials. The company also has a small contract sales business.